Investing.com - Neogen reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Neogen announced earnings per share of $0.05 on revenue of $132.35M. Analysts polled by Investing.com anticipated EPS of $0.13 on revenue of $135.74M.
Neogen shares are down 68% from the beginning of the year , still down 70.17% from its 52 week high of $47.80 set on Friday, December 31, 2021.
Neogen follows other major Healthcare sector earnings this month
Neogen's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.
Veeva Systems A had beat expectations on Wednesday, August 31, 2022 with second quarter EPS of $1.03 on revenue of $534.22M, compared to forecast for EPS of $1.01 on revenue of $530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar